Skip to search formSkip to main contentSkip to account menu

DAT regimen

Known as: Daunorubicin-AraC-Thioguanine Regimen, Daunorubicin-Cytarabine-Thioguanine Regimen, MRC AML10 Study-DAT Regimen 
A regimen consisting of daunorubicin, cytarabine (Ara-C) and thioguanine, used as an induction treatment for childhood acute myeloid leukemia (AML).
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The Russian–Lithuanian cross-border area around the Nemunas and Sesupė rivers confluence is a key area for solving… 
Review
2016
Review
2016
objective The aim of this study was to evaluate computerized monitoring of speech and swallowing outcomes and its impact on… 
2014
2014
Zelfredzaamheid is het credo in de nieuwe participatiestaat. Helaas is niet iedereen in staat of bereid het heft in eigen hand te… 
2004
2004
Se ofera spre comentariu aspectele etice care se regasesc in urmatoarele doua cazuri clinice: 1. Dna X si-a dat consimtamantul… 
2003
2003
  • B. Ale
  • 2003
  • Corpus ID: 178528397
1989
1989
Twelve patients with acute lymphoblastic leukemia (ALL) were treated with aclacinomycin A (60 mg/m2/day for five days) and VP‐16… 
1983
1983
The EETA79001 meteor i te , found i n An ta r c t i ca i n 1979, has been i d e n t i f i e d as a f o u r t h member o f t h e r… 
1960
1960
I n einer Unte r suchung iiber die Muskelermiidung durch statische Hal tearbe i ten konnte nachgewiesen werden (RoH~ERT), dal3…